Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé).
Vignot S, Daynes P, Bacon T, Vial T, Montagne O, Albin N, Emmerich J, Ratignier-Carbonneil C, Martin D, Maison P. Vignot S, et al. Among authors: ratignier carbonneil c. Front Pharmacol. 2021 Apr 28;12:635841. doi: 10.3389/fphar.2021.635841. eCollection 2021. Front Pharmacol. 2021. PMID: 33995037 Free PMC article. No abstract available.
Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts.
Maison P, Zureik M, Hivert V, Kjaer J, Hossein Khonsari R, Trifirõ G, Ratignier-Carbonneil C. Maison P, et al. Among authors: ratignier carbonneil c. Front Pharmacol. 2022 Jul 26;13:969091. doi: 10.3389/fphar.2022.969091. eCollection 2022. Front Pharmacol. 2022. PMID: 35959441 Free PMC article. No abstract available.
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience.
Belgodère L, Emmerich J, Albin N, Bacon T, Daynes P, Vignot S, Vial T, Renaud G, Le Saulnier C, Maillard-Couvreur C, Cachet M, Veyries ML, Youdarene R, Oualikene-Gonin W, Ratignier-Carbonneil C, Maison P. Belgodère L, et al. Among authors: ratignier carbonneil c. Front Public Health. 2023 Nov 17;11:1293110. doi: 10.3389/fpubh.2023.1293110. eCollection 2023. Front Public Health. 2023. PMID: 38045969 Free PMC article.
Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondes.
Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D; participants of round table N°3 of Giens XXX:; Bergmann JF, Casadevall N, Delval C, De Sahb Berkovitch R, Fagon JY, Gersberg M, Lassale C, Lechat P, Le Jeunne C, Montastruc JL, Prugnaud JL, Ratignier-Carbonneil C, Rey-Coquais C; 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Girault D, et al. Among authors: ratignier carbonneil c. Therapie. 2015 Jan-Feb;70(1):37-55. doi: 10.2515/therapie/2015003. Epub 2015 Feb 16. Therapie. 2015. PMID: 25679193 Review. English, French.
Telemedicine: what framework, what levels of proof, implementation rules.
Zannad F, Maugendre P, Audry A; participants of round table n5 of Giens XXIX : Avril Carole 4 Blaise Lucile 5 Blin Olivier 6 Burnel; Avril C, Blaise L, Blin O, Burnel P, Falise-Mirat B, Girault D, Giri I, Goehrs JM, Lassale C, Le Meur R, Leurent P, Ratignier-Carbonneil C, Rossignol P, Satonnet E, Simon P, Treluyer L. Zannad F, et al. Therapie. 2014 Jul-Aug;69(4):339-54. doi: 10.2515/therapie/2014043. Epub 2014 Aug 12. Therapie. 2014. PMID: 25230356 English, French.
Télémédecine : quel cadre, quels niveaux de preuves, quelles modalités de déploiement.
Zannad F, Maugendre P, Audry A; et les participants à la table ronde N°5 de Giens XXIX :; Avril C, Blaise L, Blin O, Burnel P, Falise-Mirat B, Girault D, Giri I, Goehrs JM, Lassale C, Le Meur R, Leurent P, Ratignier-Carbonneil C, Rossignol P, Satonnet E, Simon P, Treluyer L. Zannad F, et al. Therapie. 2014 Jul-Aug;69(4):339-46. doi: 10.2515/therapie/2014042. Therapie. 2014. PMID: 27393227 French. No abstract available.
Biosimilaires : de la technique au médicoéconomique.
Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D; et les participants à la table ronde N°3 de Giens XXX :; Bergmann JF, Casadevall N, Delval C, De Sahb Berkovitch R, Fagon JY, Gersberg M, Lassale C, Lechat P, Le Jeunne C, Montastruc JL, Prugnaud JL, Ratignier-Carbonneil C, Rey-Coquais C. Girault D, et al. Among authors: ratignier carbonneil c. Therapie. 2015 Jan-Feb;70(1):37-46. doi: 10.2515/therapie/2014233. Therapie. 2015. PMID: 27393395 French. No abstract available.
12 results